GSD:CC News and Press, Devonian Health Group Inc. From 12/19/25

Devonian Health Group Announces Grant of Stock Options Canada NewsWire QUEBEC , Dec. 19, 2025 /CNW/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF), a biopharmaceutical Company specializing in the development of prescri...

Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update Canada NewsWire Company continues preclinical studies for Thykamine™ in MASH and Fibrosis, furthering the understanding of Thykamine™'s me...

Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine™ as a Promising New Anti-Inflammatory Agent Canada NewsWire QUÉBEC , Dec. 4, 2025 /CNW/ - Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSXV: GSD) (OTCQB: D...

Devonian Health Group Reports its Fourth Quarter and Annual 2025 Financial Results and Appointment of a New Board Member Canada NewsWire Fourth quarter distribution revenues of $1.3 million Fourth quarter net loss of $0.4 million , $0.003 per share Annual distribution...

Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / Q...

Third quarter revenues increased 36% compared to 3Q24 Third quarter net loss of $0.032 per share Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), today announced financial results for its ...

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today announced the appointment of Dr. André Boulet as Chief Exe...

Canadian Investment Regulatory Organization Trade Resumption - GSD Canada NewsWire VANCOUVER, BC , April 29, 2025 /CNW/ - Trading resumes in: Company: Devonian Health Group Inc. TSX-Venture Symbol: GSD All Issues: Yes Resumption (ET): 9:30 AM 4/...

Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), announced that the TSX Venture Exchange (the “ Exchange ”) has approved its application for reinstatement of trading of the Company's common shares o...

Second quarter revenue increased 275% year over year Second quarter net loss of $0.001 per share Debt repaid in full Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), today anno...